NFKB1 and atherosclerosis: Atherosclerosis is an inflammatory pathology that accompanies the process of vascular damage, ATL I reduces LDL-induced vascular smooth muscle cell proliferation and migration, inflammatory cytokine production and MCP-1 expression, and inhibits p38-MAPK and NF-κB activation, which has beneficial effects on atherosclerosis [26].